Clark James M, Boffa Daniel J, Meguid Robert A, Brown Lisa M, Cooke David T
Section of General Thoracic Surgery, Department of Surgery, University of California, Davis Health, Sacramento, CA, USA.
Section of Thoracic Surgery, Department of Surgery, Yale New Haven Hospital, New Haven, CT, USA.
J Thorac Dis. 2019 Aug;11(Suppl 12):S1633-S1642. doi: 10.21037/jtd.2019.07.88.
The morbidity and mortality benefits of performing high-risk operations in high-volume centers by high-volume surgeons are evident. Regionalization is a proposed strategy to leverage high-volume centers for esophagectomy to improve quality outcomes. Internationally, regionalization occurs under national mandates. Those mandates do not exist in the United States and spontaneous regionalization of esophagectomy has only modestly occurred in the U.S. Regionalization must strike a careful balance and not limit access to optimal oncologic care to our most vulnerable cancer patient populations in rural and disadvantaged socioeconomic areas. We reviewed the recent literature highlighting: the justification of hospital and surgeon annual esophagectomy volumes for regionalization; how safety performance metrics could influence regionalization; whether regionalization is occurring in the US; what impact regionalization may have on esophagectomy costs; and barriers to patients traveling to receive oncologic treatment at regionalized centers of excellence.
由高手术量的外科医生在高手术量中心进行高风险手术,其在发病率和死亡率方面的益处是显而易见的。区域化是一种提议的策略,旨在利用高手术量中心进行食管癌切除术,以改善治疗效果。在国际上,区域化是在国家指令下进行的。美国不存在这些指令,食管癌切除术的自发区域化在美国仅适度出现。区域化必须谨慎权衡,不能将农村和社会经济弱势地区最脆弱的癌症患者群体获得最佳肿瘤治疗的机会限制住。我们回顾了近期的文献,重点关注:医院和外科医生每年食管癌切除量对于区域化的合理性;安全绩效指标如何影响区域化;美国是否正在进行区域化;区域化可能对食管癌切除成本产生何种影响;以及患者前往区域化的卓越中心接受肿瘤治疗的障碍。